M. Bennoun

发表

Deregulation of proteins involved in iron metabolism in hepcidin-deficient mice.

S. Vaulont, A. Kahn, G. Nicolas, 2005, Blood.

Expression of COUP-TFII in metabolic tissues during development

M. Vasseur-Cognet, I. Leclerc, A. Kahn, 2002, Mechanisms of Development.

The hepatitis B virus X gene product transactivates the HIV-LTR in vivo.

G. Natoli, O. Billet, M. Levrero, 1993, Archives of virology. Supplementum.

Efficient retroviral-mediated gene transfer into primary culture of murine and human hepatocytes: expression of the LDL receptor.

R. Benarous, P. Briand, J. Pagès, 1995, Human gene therapy.

Retroviral gene transfer for LDL receptor deficiency into primary hepatocytes.

P. Briand, D. Franco, J. Pagès, 1994, Advances in experimental medicine and biology.

Severe iron deficiency anemia in transgenic mice expressing liver hepcidin

C. Beaumont, B. Grandchamp, S. Vaulont, 2002, Proceedings of the National Academy of Sciences of the United States of America.

hepcidin-deficient mice Deregulation of proteins involved in iron metabolism in

S. Vaulont, G. Nicolas, D. Lou, 2010 .

Relationship between the intracellular level and growth inhibition of a new anthracycline 4'O-tetrahydropyranyl-Adriamycin in Friend leukemia cell variants.

H. Tapiero, A. Fourcade, J. Munck, 1985, Leukemia research.

Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis

N. Andrews, C. Beaumont, S. Vaulont, 2003, Nature Genetics.

Critical stages of tumor growth regulation in transgenic mice harboring a hepatocellular carcinoma revealed by distinct patterns of tumor necrosis factor-alpha and transforming growth factor-beta mRNA production.

S. Chouaib, J. Guillet, B. Antoine, 1997, International immunology.

Correction of mouse ornithine transcarbamylase deficiency by gene transfer into the germ line.

C. Cavard, G. Grimber, P. Briand, 1988, Nucleic acids research.

Transgenic Mice

M. Rissel, A. Guillouzo, P. Briand, 2007 .

Hepatitis B virus X gene product acts as a transactivator in vivo.

G. Natoli, O. Billet, M. Levrero, 1994, Journal of hepatology.

The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity.

B. Viollet, M. Birnbaum, D. Carling, 2003, The Journal of clinical investigation.

In vivo activation by ultraviolet rays of the human immunodeficiency virus type 1 long terminal repeat.

C. Cavard, G. Grimber, P. Briand, 1990, The Journal of clinical investigation.

The consequence of p53 overexpression for liver tumor development and the response of transformed murine hepatocytes to genotoxic agents

C. C. Fromentel, R. Gillet, G. Grimber, 2000, Oncogene.

Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice

C. Beaumont, B. Grandchamp, S. Vaulont, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Chronic hepcidin induction causes hyposideremia and alters the pattern of cellular iron accumulation in hemochromatotic mice.

N. Andrews, H. Bujard, K. Schönig, 2006, Blood.

Iron‐ and inflammation‐induced hepcidin gene expression in mice is not mediated by Kupffer cells in vivo

L. Rénia, S. Vaulont, A. Kahn, 2005, Hepatology.

Hepcidin, a new iron regulatory peptide.

C. Beaumont, S. Vaulont, A. Kahn, 2002, Blood cells, molecules & diseases.

Targeted disruption of the hepcidin 1 gene results in severe hemochromatosis.

S. Vaulont, A. Kahn, G. Hamard, 2006, Blood.

Effect of Bcl-2 expression on hepatic preneoplasia in mice.

R. Gillet, C. Cavard, G. Grimber, 2002, Cancer letters.

Retroviral infection of primary hepatocytes from normal mice and mice transgenic for SV40 large T antigen.

P. Briand, A. Kahn, J. Decaux, 1993, Experimental cell research.

Annexin 1 expression and phosphorylation are upregulated during liver regeneration and transformation in antithrombin iii sv40 t large antigen transgenic mice

R. Gillet, P. Briand, E. Solito, 2000, Hepatology.

Time-course development of differentiated hepatocarcinoma and lung metastasis in transgenic mice.

G. Grimber, P. Briand, I. Allemand, 1991, Journal of hepatology.

Conditional hepatocarcinogenesis in mice expressing SV 40 early sequences.

M. Vasseur-Cognet, C. Cavard, P. Briand, 2005, Cancer letters.

Fas-dependent apoptosis is impaired by SV40 T-antigen in transgenic liver.

P. Briand, V. Joulin, I. Allemand, 1995, Oncogene.

The amino-terminal region of SV40 large T antigen is sufficient to induce hepatic tumours in mice

G. Grimber, P. Briand, V. Joulin, 1998, Oncogene.

Oval cell proliferation in early stages of hepatocarcinogenesis in simian virus 40 large T transgenic mice.

M. Rissel, A. Guillouzo, P. Briand, 1993, The American journal of pathology.

Biochemical and cytotoxic properties of the isomeric forms of N,N'-bis[N-2-chloroethyl)-N-nitrosocarbamoyl] cystamine.

K. Tew, H. Tapiero, M. Bennoun, 1984, Biochemical pharmacology.

Fate of aclacinomycin-A and its metabolites effect on cell growth and macromolecular synthesis.

H. Tapiero, A. Fourcade, M. Bennoun, 1983, Biochemical pharmacology.

Uptake, efflux, and hydrolysis of aclacinomycin A in Friend leukemia cells.

H. Tapiero, A. Fourcade, M. Bennoun, 1982, Cancer research.